Hotline – Election Day Closure

ATTENTION: HealthWell Foundation’s hotline will be closed on Tuesday, November 3, 2020 to allow our contact center team the flexibility to safely vote. The hotline will re-open on Wednesday, November 4, 2020 at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time.  Please note: if you are contacting us about a payment or grant, it is faster to email us at grants@healthwellfoundation.org.  The HealthWell Team.

 

 

Dismiss alert
By Claire Saxton, Vice President, Education and Outreach, Cancer Support Community  |  Sep 2, 2020

CAR-T Cell Immunotherapy: What to Expect

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

By Lee Greenberger, PhD, Chief Scientific Officer, The Leukemia & Lymphoma Society  |  Aug 19, 2020

The Evolution of CAR-T Therapy

Over the past two decades there’s been tremendous progress in understanding how to harness the body’s immune system to fight cancer. Today, immunotherapy is a mainstay of cancer treatment. One of the most exciting areas of immunotherapy is CAR (chimeric antigen receptor) T-cell therapy. This treatment involves purifying a special…more.

By Real World Health Care Editorial Staff  |  Jul 22, 2020

CAR T-Cell Therapy Gave Me Back My Life

Editor’s Note: This week, Real World Health Care shares an inspirational story of a woman who was diagnosed with lymphoma and received treatment with CAR T-cell therapy. “CAR-T Cell Therapy Gave Me My Life Back” is reprinted with permission from the Association of Community Cancer Centers. Updated in April 2020,…more.

By David Sheon  |  Jul 18, 2013

Companion Diagnostics Target Therapy to the Patients Most Likely to Respond

What cancer patient would want to use trial and error with various chemotherapies when he or she could know first from a diagnostic that one agent in particular would result in the most successful outcome? A new field has emerged, companion diagnostics, to help predict a patient’s compatibility with chemotherapy or…more.

Categories: Cost-Savings
Close menu